Advocacy
Action Alert: Help Push Forward Treatments in the Time of COVID-19
The novel coronavirus pandemic has impacted the healthcare system on every level. Right now, OCRA is working alongside several cancer advocacy groups to ensure government agencies are aware of COVID-19’s real-life impact on cancer patients…
COVID-19 and Oncology Clinical Trials: An Update
(April 15) The novel coronavirus, COVID-19, has become nearly all consuming. It’s impossible to turn on the news, browse social media, or walk outside without being reminded of the new, albeit temporary, state of the world…
Action Alert: Cosponsor Johanna’s Law Reauthorization (H.R. 4560)
We need your help to strengthen critical gynecologic cancer education and awareness programs. (October 16, 2019) Recently, Rep…
Action Alert: Tell Senate – More Funding for Ovarian Cancer Research!
(April 3, 2019) We have one week to let the Senate know that we need more funding for ovarian cancer research! Thanks to your efforts, a record 158 U.S…
Update on $15 Million Increase Request for OCRP Funding
(April 1, 2019) 156 House Members have joined Reps. DeLauro and Duffy in a call for increased ovarian cancer research funding. Reps…
OCRA Spring Advocacy Day 2019 Actions
(March 20, 2019) Earlier this month, OCRA united advocates from across the country for Spring Advocacy Day on Capitol Hill…
Action Alert: Tell Congress to Increase OCRP Funding
(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through…
Statement from Audra Moran, President and CEO of Ovarian Cancer Research Alliance on the President’s FY2020 Budget
(March 12, 2019) “The President’s proposed FY2020 budget released by the White House on Monday seeks to cut medical research funding at the National Cancer Institute (NCI) by 15 percent – almost $900 million dollars compared to FY2019…
Action Alert: Protect Federal Funding for Ovarian Cancer Research
The White House has released a proposed budget for FY2018 that makes drastic cuts to the budgets for the National Institute of Health (NIH) and Centers for Disease Control and Prevention (CDC)…
Kolker Fellowship Deadline Approaching
The Kolker Fellowship commemorates the legacy of pioneering health policy advocate Ann Kolker…
OCRFA applauds FDA’s statement on ovarian cancer screening test
On September 7th, the FDA issued an important safety communication about tests marketed as ovarian cancer screening tests, including the ROCA Test developed by Abcodia Incorporated…
Action Alert: Oral Chemotherapy Parity
Join us in asking Congress to pass oral chemotherapy parity legislation today. This legislation will ensure that patients have access to the best chemotherapy drugs available, including many personalized therapies…